IL1B and pulmonary edema: By inhibiting NF-κB–dependent transcription of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and attenuating oxidative stress, deslanoside may help preserve alveolar–capillary barrier integrity, reduce endothelial permeability, and alleviate pulmonary edema.